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Abstract
Borreliaburgdorferi is a spirochetal bacterium transmitted by the Ixodes tick that causes
Lyme disease in humans due to its ability to evade the host immune response and dissemi-
nate to multiple immunoprotective tissues. The pathogen undergoes dynamic genetic alter-
ations important for adaptation from the tick vector to the mammalian host, but little is known
regarding the changes at the transcriptional level within the distal tissues they colonize. In
this study, B. burgdorferi infection and gene expression of the essential virulence determi-
nant ospCwas quantitatively monitored in a spatial and temporal manner utilizing reporter
bioluminescent borrelial strains with in vivo and ex vivo imaging. Although expressed from a
shuttle vector, the PospC-luc construct exhibited a similar expression pattern relative to native
ospC. Bacterial burden in skin, inguinal lymph node, heart, bladder and tibiotarsal joint varied
between tissues and fluctuated over the course of infection possibly in response to unique
cues of each microenvironment. Expression of ospC, when normalized for changes in bacte-
rial load, presented unique profiles in murine tissues at different time points. The inguinal
lymph node was infected with a significantB. burgdorferiburden, but showed minimal ospC
expression. B. burgdorferi infected skin and heart induced expression of ospC early during
infection while the bladder and tibiotarsal joint continued to display PospC driven lumines-
cence throughout the 21 day time course. Localized skin borrelial burden increased dramati-
cally in the first 96 hours following inoculation, which was not paralleled with an increase in
ospC expression, despite the requirement of ospC for dermal colonization. Quantitation of
bioluminescence representingospC expression in individual tissues was validated by qRT-
PCR of the native ospC transcript. Taken together, the temporal regulation of ospC expres-
sion in distal tissues suggests a role for this virulence determinantbeyond early infection.
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Introduction
Borrelia burgdorferi, the etiological agent of Lyme disease, causes a multistage infection result-
ing in cardiac, neurologic and arthritic symptoms [1–3]. Borrelial infection is mediated
through the Ixodes vector that transmits the pathogen to susceptible mammals, including
humans, during a prolonged bloodmeal [4]. Infected humans may develop a painless bull’s-
eye rash, known as erythemamigrans, at the site of the tick bite and experience flu-like symp-
toms. Early antibiotic intervention is an effective treatment for clearance of infection, but when
left untreated B. burgdorferi disseminates and colonizes distal immunoprotective niches result-
ing in severe and sustainedmorbidity. In 2013, the CDC reported that approximately 300,000
cases of Lyme disease occur in the United States each year, suggesting this is a significant
emerging disease [5].
B. burgdorferi requires complex genetic regulation to adapt to the myriad of environmental
signals it detects within the mammalian host [4,6]. B. burgdorferi alters gene expression when
changes occur in temperature, pH, metals, oxygen, CO2, and osmotic stress; however, these
environmental cues do not account for all adaptations observed from borrelial cells cultivated
in implanted dialysis membrane chambers (DMC), indicating that unknown host signals also
influence the response observed [7–20]. Borrelial virulence determinants needed for mamma-
lian infection are induced through the Rrp2-RpoN-RpoS regulatory system, as well as through
BosR,which is required for RpoS production [21–36]. This complex regulatory response is
mediated during the tick bloodmeal and within the mammalian host during infection [37–42].
OspC, a well-characterized borrelial lipoprotein, is an RpoS-regulated virulence determi-
nant and important for the establishment of early localized infection [25,35]. B. burgdorferi
ospC is required for the colonization of the mammalian dermis since ospCmutants are cleared
from the inoculation site within 48 hours after infection [25,35,43–46]. Strains in which ospC is
constitutively expressed are not able to maintain localized or persistent infectionwithout the
ability to regulate expression similar to wild-typeB. burgdorferi, suggesting that the expression
of ospC needs to be tightly coordinated to promote the successful colonization of B. burgdorferi
[47,48]. Tilly et al. demonstrated infection and dissemination of a host-adapted ospCmutant
strain suggesting this virulence determinant is exclusively required for early stages of mamma-
lian infection [44]. The role of ospC in dissemination and persistent infection in the distal tis-
sues is not fully understood, but studies have shown a potential role for OspC beyond localized
infection [49–52]. Transcripts of ospC increase in the heart over the course of infection, but
this increasemay in part be due to changes in bacterial burden [50]. Phage-display experiments
showed that OspC peptides localized to the murine heart and tibiotarsal joint more so than
other tissues [49], suggesting that OspC is needed at distal sites for optimal infection. Although
deciphering the role of OspC duringmammalian infection and its unique function has been a
challenge, evidence suggests a potential role in ligand binding and/or immune evasion [52–60].
A specific example of ligand binding is the ability of OspC to bind plasminogen, although the
exact binding site has yet to be identified [55,56]. Carrasco et al. showed that OspC has an anti-
phagocytic role and may be involved in protecting B. burgdorferi frommacrophage clearance
[61]. The importance of ospC for infection and its presence in all borrelial strains has made it
an enticing vaccine candidate, but the high degree of sequence heterogeneity and strain specific
protection have historically been stumbling blocks for its further development [62–65]. Char-
acterizing ospC expression in vivo temporally and spatially in mice would provide a modality
to track the dynamic regulation of this important borrelial virulence determinant throughout
experimental infection.
In vivo imaging technology enables the tracking of infectious pathogens in a non-invasive
manner over time and locale [66–74]. The mouse model is an important tool to understand
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borrelial pathogenesis and genetic responses in the host environment that can not be addressed
by in vitromodalities. To this end, B. burgdorferi was transformed with a constitutively
expressed, codon optimized firefly luciferase (PflaB-luc) on a shuttle vector that is designed to
be maintained throughout infection [75,76]. Our previous work compared the infectivity pat-
tern of bioluminescent borrelial bbk32 and dbpAmutant strains relative to wild-typeB. burg-
dorferi [75]. From this analysis we determined that a bbk32mutant was incapable of
establishing a strong localized infection relative to wild-typeB. burgdorferi, but was able to dis-
seminate and persist, albeit at lower levels, consistent with our prior qualitative assessment of
the bbk32mutant [75]. This powerful approach provides the ability to track subtle, but signifi-
cant, phenotypic differences seen betweenmutant strains during active infection in a manner
not achieved by traditional endpoint studies. This technology has also been applied in other
bacterial systems to evaluate changes in gene expression during the course of infection, thus
providing insight regarding genetic mechanism employed in response to interaction with the
host environment [77,78]. Implementing the same strategy during borrelial murine infection
may provide important insight into how specificB. burgdorferi genes are regulated throughout
the stages of experimental Lyme borreliosis.
In this study, we evaluated expression of ospC utilizing a bioluminescent reporter driven by
the ospC promoter in a temporal and spatial context. The goal was to develop a borrelial in vivo
reporter system to observe how ospC expression occurred during infection within host micro-
environments of tissues following B. burgdorferi dissemination. The data presented herein is
the first demonstration monitoring B. burgdorferi ospC gene expression with bioluminescence
as a readout over time in live mice. Although we predicted that ospC expression would be lim-
ited to early stages of infection, surprisingly, ospC displayed unique expression patterns in vari-
ous tissues at distinct time points throughout infection. The infectious load of B. burgdorferi
differed between distal sites and across time points. Our results indicate that high-level ospC
expression is not required for localized infection, but instead, low-level ospC expression is suffi-
cient for colonization. Furthermore, continued ospC expression was observed in distal sites
later in infection, suggesting a potential new role for OspC in secondary colonization or
persistence.
Materials andMethods
Bacterial strains and plasmids
E. coli strains were grown in Lysogeny broth (LB) media under aerobic conditions at 37°C
(Table 1). Concentrations of antibiotics used in E. coli for selective pressure are as follows:
kanamycin, 50 μg/ml and spectinomycin, 50 μg/ml. B. burgdorferi strains were grown in
BSK-II media supplemented with 6% normal rabbit serum (Pel-Freez Biologicals, Rogers, AR),
referred to as complete BSKII, under conventional microaerobic conditions (1% CO2, 32°C)
(Table 1) [79,80]. Borrelial strains were grown under antibiotic selective pressure when appro-
priate with kanamycin at 300 μg/ml. The Institute Biosafety Committee at Texas A&MUniver-
sity approved the use of infectiousB. burgdorferi described in this study.
Generated constructs and modification of B. burgdorferi
A bioluminescent ospC reporter shuttle vector, pJH410, was generated through the PCR ampli-
fication of the native ospC promoter including 250 bp upstream from the ATG start codon for
ospC and borrelial codon optimized luc (Table 1) [36,81]. Primers for cloning are listed in
Table 2. PospC was amplified with NcoI restriction sites, cloned into pCR2.1 TOPO, and then
transformed into Mach-I E. coli cells (Life Technologies). PospC was cloned into pJSB161 [76] at
the NcoI site, transformed into Mach-I E. coli cells and screened for insert and orientation,
ospCReporterExpression in B. burgdorferi
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resulting in pBS103. PospC-luc was PCR amplified with PstI restriction sites and cloned into
pCR8/GW/TOPO (Life Technologies), resulting in pJH409. The vectors were screened by
restriction enzyme digest and verified through dideoxy sequencing. PospC-luc was ligated into
pBBE22 at the PstI to yield the final pJH410 construct.B. burgdorferi strain ML23 was made
competent and transformed with pJH410 as describedpreviously [82,83]. Transformants were
selected for resistance to kanamycin and all putative isolates were screened for PospC-luc shuttle
vector and plasmid content by PCR followed by in vitro luminescence assay [75,76].
A construct for quantification of ospC expression was generated by amplifying a region of
cp26 containing ospC, cloning into pCR2.1 TOPO (Life Technologies), and transforming this
construct into Mach-I E. coli cells (Tables 1 & 2). The resulting plasmid was designated pOspC
(Table 2).
Table 1. Strains and Plasmidsused in this study.
B. burgdorferi strains used in this study:
Strain Genotype Reference
ML23 Clonal isolate lacking lp25 [87]
ML23 pBBE22luc Missing lp25, complemented with BBE22 and PflaB-luc [75]
ML23 pJH410 Missing lp25, complemented with BBE22 and PospC-luc this study
E. coli strains used in this study:
Strain Genotype Reference
Mach-1TM-T1R Φ80lacZΔM15 ΔlacX74 hsdR (rk-,mk+) ΔrecA1398 endA1 tonA Life Technologies
Plasmids used in this study:
Plasmid Comments/Source/Reference Resistance
pCR2.1 TOPO Life Technology PCR cloning vector kanR
pCR8/GW/TOPO Life Technology PCR cloning vector specR
pJSB161 pJD7 carrying a promoterless luc [76] specR
pBS103 pJD7 with PospC-luc specR
pJH409 pCR8/GW/TOPO with PospC-luc flanked by engineeredPstI sites specR
pBBE22 borrelial shuttle vector pBSV2 containing pncA (bbe22) fragment to restore infectivity in ML23 [100] kanR
pJH410 pBBE22 carryingPospC-luc cloned into PstI site kanR
pRecA pCR8-TOPO carryingB. burgdorferi recA [101] specR
pβactin pCR8-TOPO carryingmurine βactin [102] specR
pOspC pCR2.1 carryingospC fromB. burgdorferi kanR
doi:10.1371/journal.pone.0162501.t001
Table 2. Primers used in this study.
Primer Purpose Sequence
PospCF-NcoI Cloning GTATA AACGCCATGGTCTCTAATTC
PospCR-NcoI CTTTTCCATGGATTTGTGCCTCC
PospCF-PstI Cloning ACGCCTGCAGGCCTGAGTATTCATTA TATAAGT
lucR-PstI ACGCCTGCAGAAGCTTTTATTATACAGC
ospCF Cloning GGGATCCAAAATCTAATACAA G
ospCR GCCAAAACCGTTTAAGCCTAC
RTospCF qRT-PCR CGGATTCTAATGCGGTTTTACTTG
RTospCR CAATAGC TTTAGCAGCAATTTCATCT
nTM17FrecA qPCR GTGGATCTATTGTAT TAGATG AGGCTCTCG
nTM17RrecA GCCAAAGTTCTGCAACATTAACACCTAAAG
qPCR-Bactin-F qPCR ACGCAGAGGGAAATCGTGCGTGAC
qPCR-Bactin-R1 ACGCGGGAGGAAGAGGATGCGGCAGTG
doi:10.1371/journal.pone.0162501.t002
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Western immunoblot analysis
Borrelial cells were pelleted and resolved by sodium dodecyl sulfate-polyacrylamidegel electro-
phoresis (SDS-PAGE) and transferred to a PVDF membrane for Western analysis as previ-
ously described [7,8,84]. Protein production was assessed using mouse monoclonal antisera to
B. burgdorferiOspC (generously provided by Richard Marconi, Virginia Commonwealth Uni-
versity) and flagellum (Affinity BioReagents, Golden, CO) or goat polyclonal antisera to Firefly
luciferase (AbCam Inc., Cambridge,MA), followed by incubation with rabbit anti-mouse IgG
conjugated to horseradish peroxidase (HRP) or rabbit anti-goat IgG HRP, respectively [52,75].
The membrane bound immune complexes were visualized using theWestern Lightning
ChemiluminescenceReagent Plus detection system (Perkin Elmer).
In vitro bioluminescenceassays
B. burgdorferi was grown to mid-log phase at pH 7 or pH 8 and concentrated to 108 cells/ml
for ML23 pBBE22luc (PflaB-luc) and ML23 pJH410 (PospC-luc). Cells were serially diluted from
107 to 100 cells/ml and 100 μl of each sample was transferred to a white flat-bottommicrotiter
96 well plate. Luminescencewas measured using 2104 EnVision Multilabel Reader (Perkin
Elmer, Inc., Waltham, MA) as previously described [75]. The different cell concentrations of
each strain were treated with a final concentration of 667 μMD-luciferin (Research Products
International Corp., Mt. Prospect, IL) in PBS and immediately measured for luminescence
[75,69]. Cell samples for each strain from three independent cultures were measured for lumi-
nescence (photons/sec), averaged, and standard error calculated.
In vivo and ex vivo bioluminescence studies and luminescence
quantitation
Six to eight week old female Balb/cmice (Charles Rivers) were infectedwith 105 ML23 pBBE22-
luc or ML23 pJH410 by ventral intradermal injection. Balb/cmice are the preferred strain for in
vivo imaging due to the lack of melanin in the skin and fur, but have a distinct pathology and
higher ID50 in response B. burgdorferi infection relative to C3Hmice [85]. An inoculumdose
of 105 was used for this study due to maximize the measurable bioluminescence signal from
PospC-luc infectedmice. Mice were treated with 5 mg D-luciferin dissolved in 100 μl PBS by
intraperitoneal injection 10 minutes prior to imaging with an IVIS Spectrum live animal imag-
ing system (Perkin Elmer, Waltham, MA). As a negative control for background luminescence,
one infectedmouse in each group did not receive D-luciferin [75]. Mice were randomly selected
and in vivo imaging was performed 1 h and 4, 7, 10, 14 and 21 days after infectionwith the
abovementioned borrelial strains using the methods previously described [69,82]. Luminescence
was measured using 1 and 10 min exposures to obtain images for quantification and visual
representation, respectively. Images were analyzed using Living Image Software from Perkin
Elmer. Regions of interest (ROI) tool were selected to measure the luminescence in photons/
second [p/s] from exposure images with 600–600,000 counts using an equal area of the whole
body for all mice in all experiments. Background luminescencewas subtracted from lumines-
cence values for normalization. Luminescence of D-luciferin treated mice was averaged and
standard error determined after normalization. All images from the 10 min exposures were
treated equally when corrected for background and depicted by the radiance scale.
Housing, diet, and care of mice were under standard ABSL-2 parameters under the supervi-
sion of a Texas A&MUniversity veterinarian.Mice were monitored daily and evaluated for
general health and activity. Throughout the 21 day infection no illnesses or unexpected deaths
occurred and efforts were made to minimize any discomfort to the mice. Isoflurane was utilized
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as an anesthetic for IVIS imaging. At designated time points mice were euthanized in accor-
dance with guidelines of the American Veterinary Medical Association (AVMA) and as
approved by the Texas A&MUniversity Institutional Animal Care and Use Committee
(IACUC).
To maximize bioluminescence during ex vivo imaging of infected tissues, mice were given a
double bolus of D-luciferin by intradermal injection that then circulated for 10 minutes. Mice
were individually sacrificed for tissues to be harvested in a timely manner to determine tissue
localization of bioluminescence observedduring in vivo imaging that measures through various
tissues simultaneously. Harvested tissues were transferred to a 4 mMD-luciferin and 2 mM
ATP soak for 3 minutes. Ex vivo bioluminescent tissues were imaged for 1 and 10 minutes, sim-
ilar to in vivo imaging. Quantitation of tissue bioluminescencewas determined by radiance
(p/sec/cm2/sr) to account for the area difference of each tissue. Following imaging, tissues were
stored in RNAlater (Life Technologies) at -80°C until isolation of total RNA. Skin samples
were processed for qPCR.
DNA and RNA extraction ofB. burgdorferi from infected tissues
DNA was extracted from skin samples using RocheHigh Pure PCR template preparation kit as
previously described [84]. RNA was extracted from infected tissue by phase separation with
Trizol per manufacture instructions (ThermoFisher). RNAlater stored tissues were homoge-
nized on ice in Trizol. Samples were incubated at room temperature for 5 minutes, then 200 μl
of chloroform per ml of Trizol was added to each sample, and incubated at room temperature
for 3 minutes. Phase separation occurred by centrifuging samples at 12,000 x g for 15 minutes
at 4°C. The RNA-containing upper aqueous layer was precipitated with an equal volume of
cold 100% isopropanol and washed twice with 75% EtOH to remove salt. 30 μg of total RNA
was treated with 5 units of Roche recombinant DNase (RNase-free) per the manufacture
instructions to remove contaminating DNA and purified by standard phenol-chloroform-isoa-
myl extraction followed by ethanol precipitation with 10 μg of glycogen per sample.
Quantitative PCR and RT-PCR analysis
The Applied Biosystems ABI 7500 real time PCR system (ThermoFisher) was used to deter-
mine genomic equivalents as previously described [86]. Borrelial genomic equivalents were
evaluated using primers nTM17FrecA and nTM17RrecA to B. burgdorferi recA and mouse
β-actin copies were detected using primers Bactin_F and Bactin_R1 as previously described
(Table 2). The numbers of recA and β-actin copies were calculated by establishing a Ct standard
curve of known amount of each gene for comparison to the Ct values of the experimental sam-
ples. 100 ng of each experimental sample was measured in triplicate and values are displayed as
copies of B. burgdorferi recA per 106 mouse β-actin.
Borrelial mRNA were converted to cDNA with 3 μg DNase treated total RNA with Super-
script-II Reverse Transcriptase in a 20 μl reaction as per the manufacturers instructions (Ther-
moFisher). Transcripts of ospC were quantified using PowerUp Sybr Mastermix using 2.5 μl
cDNA and primers listed in Table 2 [7]. The numbers of transcript copies were calculated by
establishing a Ct standard curve of known amount ospC for comparison to the Ct values of the
experimental samples. All samples were measured in triplicate and values are displayed in cop-
ies of ospC for the entire tissue.
Statistical analyses
One-way analysis of variance (ANOVA) was used to evaluate the significance of the main
effects and interactions among variables to determine statistical significance in PflaB-luc or as
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represented by photons/sec (in vivo) or radiance (ex vivo) through IVIS imaging using Graph-
Pad Prism (GraphPad Software, Inc, La Jolla, CA). Bioluminescence value for each individual
mouse or tissue in a group and time point was utilized for ANOVA analysis to determine sig-
nificant changes over the course of the 21 day infection.Mann-Whitney one-tail test compared
medians of two groups to determine significance. P-values less than 0.05 were considered sig-
nificant for all statistical analyses. Correlation between PospC-luc radiance and qRT-PCR
native ospC was also calculated using GraphPad Prism. In permutation tests, we computed the
sampling distributions, also referred to as random distribution, of the differences in PospC-luc/
PflaB-luc radiance ratios across time or between set time points. To calculate these distributions,
individual PospC-luc and PflaB-luc radiance values were randomly shuffled (10,000 times) to
form new ratios that were then differenced between time points. The distribution these random
differences estimates the null hypothesis of no significant change in the ratio with time. The
difference in the ratio actually observedwas compared against this null distribution to deter-
mine the probability that a difference as great as, or greater than, the observeddifference could
occur by chance. Permutation tests were performed using R, a freely available language and
environment for statistical computing and graphics (ver. 3.2.3; https://cran.r-project.org/).
Ethics statement
Animal experiments were performed in accordance to National Institute of Health (NIH) Guide
for Care and Use of LaboratoryAnimals. Animal experiments also followed the guidelines of
the Association for Assessment and Accreditation of LaboratoryAnimal Care (AAALAC).
Approval for animal procedures was given by the Texas A&MUniversity Institutional Animal
Care and Use Committee (IACUC). Mice were euthanized in manner that conforms to the
guidelines put forth by the AVMA and was approved by the Texas A&MUniversity IACUC.
Results
Evaluation of the ospC reporter in cultivatedB. burgdorferi
Previous studies utilized a codon optimized firefly luciferase (luc) in B. burgdorferi as an in
vitro transcriptional reporter and for detection of live B. burgdorferi during experimental infec-
tion [75,76]. The high level of sensitivity observed in vivowith the constitutively expressed luc
gene indicated that the systemmight be adapted to characterize the temporal and spatial
expression patterns of specific borrelial genes in the mammalian model. To test this, we chose
to track the expression of ospC due to its importance in the infectious process of B. burgdorferi.
To this end, we fused the ospC promoter (PospC) to the luc reporter and assessed its signal rela-
tive to light generated from luc linked to the constitutively expressed flaB promoter (PflaB). The
B. burgdorferi bioluminescent reporter strains to monitor ospC and flaBwill be referred to as
PospC-luc and PflaB-luc for this study. To test whether the bioluminescence driven by the PospC
reporter construct correspondedwith the known in vitro expression patterns for ospC in
response to environmental changes, PospC-luc was grownmicroaerophilically at 32°C, pH 8 or
pH 7 (Fig 1) [13]. Serving as a negative control, ML23 pBBE22luc, referred to in this study as
the PflaB-luc strain, was cultivated under the same conditions. As expected, PflaB-luc biolumi-
nescence did not change in response to pH while the PospC-luc was 4.6-fold higher at pH 7 rela-
tive to pH 8 (Fig 1A). Western analysis of the native OspC in PospC-luc and PflaB-luc B.
burgdorferi demonstrated higher levels of protein production at the lower pH as expected
(Fig 1B). Antibody against the Firefly luciferase (Luc) protein showed an increase in Luc at
pH 7 when linked to PospC, but equal production in the PflaB-luc strain independent of pH dem-
onstrating that PospC-luc regulates bioluminescence and Luc production in the same manner as
native ospC/OspC in response to an environmental cue (Fig 1B) [13].
ospCReporterExpression in B. burgdorferi
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Temporal evaluation of in vivo borrelial infection and ospC expression
We evaluated in vivo ospC expression during experimental infection utilizing the PospC-luc
reporter strain and, based on our prior work [75], compared this to constitutively expressed
PflaB-luc levels. As observed in previous studies, a strong localized infection developed 4 days
following infectionwith the PflaB-luc strain around the site of inoculation followed by spread
throughout the skin evident at day 7 and out to day 21 with fluctuations in overall emission
and regions of bioluminescent intensity (Figs 2A & 3A) [75]. PflaB-luc radiance was signifi-
cantly different (p = 0.0132) over the 21 days monitored indicating bacterial load fluctuates
during the course of infection (Figs 2A & 3A). Bioluminescence emitted from PospC-luc infected
mice is substantially lower than the constitutively expressed luciferase at all time points except
shortly after inoculation (Figs 2 & 3). For example, luminescence driven by PflaB is 16.98-fold
and 30.63-fold higher than PospC on day 4 and 14 post-inoculation, respectively (Fig 3A).
Fig 1. Characterizationof a bioluminescentB. burgdorferiPospC reporter strain.The response of
borrelialospC reporterstrain to pH was assessed to determine the validity of PospC-luc relative to native
OspC production.PflaB-luc and PospC-luc B. burgdorferi strains were grown at pH 7 and pH 8 to mid-log
phase to assess in vitro luminescence assay and protein production viaWestern blot analysis. (A) PflaB-luc
and PospC-luc cultureswere serial diluted from 106 to 10 cells, treatedwith D-luciferin, and luminescence was
measured in photons/sec. PflaB-luc pH 7 (red squares) and PflaB-luc pH 8 (black circles) did not differ in
bioluminescence. PospC-luc pH 7 (blue squares) induces greater luminescence relative to PospC-luc pH 8
(green circles). Values represent three independent cultures that were normalized to background and
averaged. Error bars represent standard error. (B) Differential protein production of Luc in PospC-luc reporter
strain in response to pH reflects changes observed for the native OspC in PflaB-luc and PospC-luc. Cell lysates
of PflaB-luc and PospC-luc at pH 7 or pH 8 were immunoblotted and probedwith anti-sera against OspC, FFluc
and FlaB that served as a loading control.
doi:10.1371/journal.pone.0162501.g001
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PospC-luc radiance is the same as PflaB-luc at the time of infection (Day 0) and likely represents
ospC expression under in vitro cultivation conditions (Fig 3A). To accurately access ospC
expression changes, as represented by bioluminescence, borrelial burden was taken into
account by determining the ratio of PospC-luc light emission relative to PflaB-luc biolumines-
cence (Fig 3B). The data show that following infection, light from the PospC-luc reporter
declines at day 4 relative to the overall population of B. burgdorferi as assessed by PflaB-luc
expression. The PospC-luc peaks at day 7 with 2.25x106 photons/sec (p/s) representing 36%
of the signal relative to PflaB-luc. PospC-luc emits significantly lower luminescence relative to
PflaB-luc throughout the 21 day infectionwith the lowest luminescence observedat day 14 coin-
cident with possible antibody class switching (Figs 2B & 3A) [80]. The PospC-luc/PflaB-luc ratio
reaches the highest level at day 7 followed by a decrease on day 10 and 14 then increases again
on day 21. Permutation analysis of the PospC-luc/PflaB-luc values between time points indicated
a statistical difference for all possible comparisons with p-values ranging from 0.0121 to
0.0465, except when day 4 is compared relative to day 21 (p-value = 0.0927). Taken together,
the expression of ospC over an extended period, as represented by PospC-luc throughout a 21
day infection, suggests that B. burgdorferi expresses this lipoprotein at distal sites, albeit at low
Fig 2. Temporal monitoring of PflaB-luc and PospC-luc expressingB. burgdorferiduringexperimental infection.Balb/cmice were infected with PflaB-
luc (A) or PospC-luc (B) reporterstrains at 105 by ventral intradermal infection, treatedwith D-luciferin and imaged by IVIS at 0, 4, 7, 10, 14 and 21 days post-
infection. A background controlmousewas included in each group that was infected with luminescentB. burgdorferi but not treatedwith D-luciferin; such
mouse is shown in the far left position of each image. D-luciferin treatmentor the lack thereof is designated by a + or -, respectively. A 10minute exposure
was utilized to obtain images. Normalization to subtract background was performed per strain for all time points displayed in the color spectrumposition
under the images. PflaB-luc and PospC-luc images are set on individual scales to display the full spectrumof bioluminescence. (A) PflaB-luc imageswere
normalized to radiance range of 6.95x103-1.83x105 p/sec/cm2/sr. One-way ANOVA followed by Tukey’s MultipleComparison test was performed to
determine significant difference resulting in a p-value of 0.0132. A p-value < 0.05 is considered significant. (B) PospC-luc imageswere normalized to
radiance range of 2.38x103-1.1x105 p/sec/cm2/sr. One-way ANOVA followed by Tukey’s MultipleComparison test was performed to determinesignificant
difference resulting in a p-value of 0.0009. A p-value < 0.05 is considered significant.
doi:10.1371/journal.pone.0162501.g002
ospCReporterExpression in B. burgdorferi
PLOSONE | DOI:10.1371/journal.pone.0162501 September 9, 2016 9 / 27
levels within the total population. Furthermore, this spatial expression pattern suggests that
OspC is needed for more than just initial colonization and, as such, may play an additional
putative role in borrelial persistence.
Quantificationof bacterial load of PospC-luc and PflaB-luc infected tissue
To determine whether the PospC-luc and PflaB-luc strains infectedmice equivalently, flank skin
samples were taken from near the inoculation site to quantify bacterial load. Total DNA from
day 10 and 21 post-infectionmurine skin samples was evaluated for copies of B. burgdorferi
recA per 106 murine β-actin by qPCR (Fig 4). Bacterial loads were not significantly different
between PospC-luc and PflaB-luc skin samples at day 10 and 21 post-infectionwith p-values of
Fig 3. Quantitation of PflaB-luc and PospC-luc expressingB. burgdorferiusing bioluminescent readout.
Five Balb/cmice were infected with 105 PflaB-luc or PospC-luc containing B. burgdorferi and 4 mice treated
with D-luciferin for imaging 0, 4, 7, 10, 14, and 21 days post-inoculation for bioluminescent imaging. (A)
Quantitation of 1 minute exposures was performed. At all time points the wholemousewas measured to
obtain a measurement in photons/sec, representing total flux. Bioluminescence from the 4 mice treatedwith
D-luciferinwas normalized by subtracting the measurement from the no D-luciferin control and averaged.
Blue circles represent PflaB-luc and red squares PospC-luc. Error bars represent standard error. One-way
ANOVA analysis resulted in statistical significance for PflaB-luc and PospC-lucwith a p-value of 0.0132 and
0.0262, respectively. (B) To assess the expression of ospC independent of changes in borrelial load, the ratio
differential of PospC-luc and PflaB-lucwas calculated and represented on the y-axis. Permutation analyses
comparing time points to each other found statistically significant differences (p < 0.05) between all
comparisons, except between day 4 and day 21.
doi:10.1371/journal.pone.0162501.g003
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0.22 and 0.94, respectively. These results indicate PospC-luc and PflaB-luc infectedmice contain
similar number of borrelial cells; therefore, differences in luminescence do not reflect a differ-
ential in B. burgdorferi presence but instead expression from the reporter utilized.
ospC expression is elevated in the skin and heart during early
disseminated infection
Localization of bioluminescent B. burgdorferi to track infection or evaluate gene expression has
its limitations in vivo due to the dispersal of borrelial cells to numerous tissues and the mainte-
nance of the spirochetes in the murine dermis that cloaks the light generated in underlying tis-
sues inhibiting the ability to draw conclusions regarding the localization of B. burgdorferi or
ospC expression in deeper tissues. As such, it was necessary to perform ex vivo imaging of spe-
cific tissues to attribute quantitative bioluminescent signal to individual sites. The evaluation of
temporal and tissue specific bacterial burden and ospC expression was performed by ex vivo
bioluminescence imaging and quantitation of tissues following in vivo assessment of mice
(Fig 5 & S1 Fig). Skin, inguinal lymph node, heart, bladder, and tibiotarsal joint were harvested
Fig 4. Validation of equivalent bacterial load of PflaB-luc and PospC-luc infectedBalb/cmice.Skin
samples from adjacent to the inoculation site of Balb/c mice infected with 105 PflaB-luc or PospC-luc on day 10
(A) or day 21 (B) following inoculationwere harvested for qPCR analysis of borrelial genomes (recA) per
copies of 106 β-actin. Horizontal bars denotes average copies of recA per 106 β-actin and error bars
represent standard error. Statistical analysis using the Mann-Whitney test indicated a lack of significance
between the PflaB-luc and PospC-luc at day 10 and 21 post-infection with p-values of 0.2222 and 0.9444,
respectively.
doi:10.1371/journal.pone.0162501.g004
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Fig 5. Temporal and spatial expression ofB. burgdorferi containingPflaB-luc and PospC-luc in murine tissues.Skin,
inguinal lymph node, heart, bladder, and tibiotarsal joint, fromPflaB-luc or PospC-luc infected Balb/c mice were quantitatively
assessed for bioluminescent emission at 4, 7, 10, 14 and 21 days post-infection. Four of the five mice were treatedwith a
double bolus of D-luciferin and the remaining mouse served as a background control for normalizationof ex vivo tissues.
The—represents the no luciferin control and + designates the tissues treatedwith D-luciferin. Tissues were evaluated for
ospCReporterExpression in B. burgdorferi
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at day 4, 7, 10, 14, and 21 post-infection. Images were normalized to background for all time
points for each tissue and strain (Fig 5).
Skin frommice infected with PflaB-luc reached the highest level of radiance
(1.1x105 p/sec/cm2/sr) and thus bacterial load on day 4 (Fig 5A & S1A Fig). One-way ANOVA
analysis of PflaB-luc skin radiance indicated statistically significant changes in bacterial burden
over the 21 day infection (p = 0.0082). PospC-luc emission in skin flank peaked at day 7 with
1.1x104 p/sec/cm2/sr and displayed the lowest luminescence on day 14, but continued to dem-
onstrate low-level expression of ospC throughout the 21 day infection (Fig 5A & S1A Fig). The
ratio of PospC-luc/PflaB-luc representing ospC expression relative to the overall borrelial infec-
tion reached 0.82 on day 7, followed by a dramatic absence of detectable PospC-luc at day 14,
and partial recovery by day 21 to a ratio of 0.073 (Fig 5A). Permutation analyses, comparing all
combinations PospC-luc/PflaB-luc randomly for each time point, indicated all were significantly
different across all time points with p-values ranging from 0.0001 to 0.0151. Taken together,
these data show that the expression of ospC and B. burgdorferi burden in the skin varies over
time and are maintained after dissemination from the inoculation site.
Previous studies have detected ospC transcript in the heart of mice up to two weeks follow-
ing infection using endpoint analyses [37,50]. Furthermore, phage display that presented OspC
peptides localized to the heart [49]. The presence of B. burgdorferi in the murine heart increases
dramatically and significantly during the 21 day infection (p = 0.0008), specifically at day 14
and 21 relative to earlier time points as observed in PflaB-luc infected hearts (Fig 5B & S1B Fig).
Over the course of infection PospC-luc radiance increases along with PflaB-luc intensifying that
reaches maximum bioluminescence at day 21 (S1B Fig). The higher ratio of PospC-luc/ PflaB-luc
seen as 1.35, 0.65, and 0.92 is observedduring day 4, 7, and 10 of infection, respectively, and
are not significantly different (Fig 5B). At day 14 and 21, normalizing the PospC-luc radiance
for the dramatic increase of B. burgdorferi in the heart results in a ratio of 0.45 and 0.63 for
PospC-luc/PflaB-luc that is significantly lower than early time points (Fig 5B), suggesting that the
previously observed increased ospC transcription in the heart was due to an elevated bacterial
load and not increased ospC expression [37,50]. Our data suggest B. burgdorferi induces ospC
expression in the heart during the first 10 days following infection, which is contrary to previ-
ously reported data that did not take into account the B. burgdorferi load within the heart
[37,50].
bacterial load or ospC expression as representedby PflaB-luc and PospC-luc, respectively. Normalization to subtract
background was performedper strain for all time points displayed in the color spectrumposition under the images. PflaB-luc
and PospC-luc images are set on individual scales to display the full spectrumof bioluminescence over the experimental time
course. Measurable radiance above background is detectable on all days evaluated in all tissues with the exception of
PospC-luc infected inguinal lymph node that emitsminimal luminescence. Graphs for each tissue display the ratio of PospC-luc/
PflaB-luc to depict the expression of ospC as measured by PospC-luc relative to bacterial load (scored by PflaB-luc) for a given
time point. The PospC-luc/PflaB-luc ratio underwent permutation analyses comparingall time points to determinestatistical
significance. (A) The radiance range of skin at the site of inoculation for both strains is 4.9e3-1.83e5 p/sec/cm2/sr. All
comparisons have a p-value < 0.05. (B) Heart radiance for PflaB-luc is 4.3e2-1.1e4and PospC-luc is 3.92e2-3.9e3 p/sec/cm2/sr.
Two comparisons, day 4 versus day 21 and day 7 versus day 14, were not statistically significant. Remaining comparisons
were significantly different (p-value<0.05). (C) Inguinal lymph node radiance for PflaB-luc is 1.1e3-1.1e4 and PospC-luc is
8.32e2-1.5e3 p/sec/cm2/sr. Comparisons were statistically significantwith p-values of 0.0160 or less, except day 10 versus day
21. (D) Bladder radiance for PflaB-luc is 1.1e3-5e4 and PospC-luc is 3.78e2-1.1e4 p/sec/cm2/sr. There is statistical difference
between early time points (day 4, 7, & 10) and late time points (day 14 & 21) with p-values no greater than 0.0305. (E)
Tibiotarsal joint radiance for PflaB-luc is 1.15e3-1.15e5 and PospC-luc is 4.95e2-1.1e4 p/sec/cm2/sr. All comparisons were
statistically different (p-value < 0.05), except for day 4 versus day 21.
doi:10.1371/journal.pone.0162501.g005
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Inguinal lymph node colonization and induction of ospC expression
B. burgdorferi disseminates to the inguinal lymph node and remains colonized in this tissue
throughout infection despite the presence of numerous cells involved in host immunity (Fig 5C
& S1C Fig) [80,87]. Bioluminescence of PflaB-luc is highest in the inguinal lymph node at day 4
and 21 post-infection and signal was reduced at day 7, 10, and 14 (S1C FIg). Bacterial burden
differed significantly (p = 0.0381) throughout the 21 day periodwith the most dramatic
decrease in load occurringbetween day 4 and 7 post inoculation. PospC-luc bioluminescence
was the lowest in the inguinal lymph node relative to other evaluated tissues in this study, but
above the threshold of detection necessary for quantitation, and remains at a similar level of
radiance throughout infection.When bacterial burden is taken into account, the PospC-luc/
PflaB-luc ratio is the highest at day 7 at 0.44 due to a significant reduction of borrelial cells, but
stays relatively low at the remaining time points with a PospC-luc/PflaB-luc ratio of 0.12 or less
(Fig 5C). Permutation analysis determined that the PospC-luc/PflaB-luc ratio at day 10 and 21
was not statistically significant, but all other comparisons had a p-value less than or equal to
0.016. We conclude that the inguinal lymph node is readily colonized by B. burgdorferi with
moderate changes in bacterial load after 7 days of infection. The low level expression of ospC in
B. burgdorferi cells colonizing the inguinal lymph node suggesting a minimal or inhibitory role
for OspC in this locale.
Expression of ospC persists following secondary colonization of the
bladder and tibiotarsal joint
Previous work suggests that OspC is important for early infection, but not for late infection in
the murine model, while other studies suggest OspC plays a role as a dissemination facilitating
factor [43–45,51,88].We evaluated PospC-luc in distal niches, e.g., the bladder and tibiotarsal
joint, to determine the expression of ospC in these tissues. The PflaB-luc strain initially emits
low radiance of 242.32 p/sec/cm2/sr in the bladder at day 4, peaks at day 7 post-infection, and
then steadily declines out to day 21 with radiance of 3,799 and 1,918 p/sec/cm2/sr, respectively
(S1D Fig). One-way ANOVA analysis of PflaB-luc infected bladders indicated a significant dif-
ference (p = 0.0056) when comparing all time points. The expression of PospC-luc in the bladder
is low relative to PflaB-luc with the highest bioluminescence observedon day 10 and 21 (S1D
Fig). Normalization of bladder PospC-luc expression relative to bacterial load demonstrates
peaks in the overall ospC expression ranging from 0.07–0.14 on day 4, 10, and 21 following
infection. The ratio of PospC-luc/PflaB-luc radiance in the murine bladder is significantly differ-
ent between all time points by permutation analysis, with p-values range ranging from 0.0126
to 0.0149, with the exception of the day 7 and day 14 comparison (p-value = 0.7528; Fig 5D).
Mice infected with the PflaB-luc B. burgdorferi strain reached a higher average bacterial load
within tibiotarsal joints over the course of infection that differed from the bladder with the
radiance increasing significantly to 20,053.1 p/sec/cm2/sr by day 14 (p<0.05), followed by a
42% reduction at day 21 (S1E Fig). Joints infectedwith the PflaB-luc strain showed significant
changes in radiance during infection (p = 0.0009) by one-way ANOVA analysis. The murine
bladder and tibiotarsal joint share a similar PospC-luc bioluminescence pattern with peaks at
day 4, 10, and 21 and valleys at day 7 and 14 when normalized to borrelial burden (Fig 5D &
5E). When normalized for bacterial burden, expression of ospC is slightly increased in the joint
relative to the bladder such that a similar expression pattern is seen with ratios of 0.21 on day
4, 0.05 on day 10, and 0.13 on day 21 post-infection (Fig 5E). Tibiotarsal joint PospC-luc/PflaB-luc
is essentially the same at day 4 and 21, but statistically significantly different between the other
time points with p-values no greater than 0.0163. Gene expression patterns of ospC, in the
murine bladder and tibiotarsal joint, as assessed by PospC-luc bioluminescence, suggest a role for
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this lipoprotein in later stages of infection in addition to its known role in the early infectious
process [43–45].
Correlationof ex vivo bioluminescenceand ospC expression in
PospC-luc infected tissues
The representation of ospC expression by ex vivo bioluminescenceB. burgdorferi PospC-luc
reporter strain was tested to determine if the light detected correlated with native ospC tran-
script levels within mammalian tissues. Hyde et al. previously demonstrated a strong correla-
tion between PflaB-luc bioluminescence and B. burgdorferi genomic copies in murine skin,
suggesting that bioluminescence accurately depicts borrelial burden [75]. To determine if bio-
luminescence driven by PospC also approximates native gene expression of ospC in infectious
B. burgdorferi, total RNA was isolated from tissue samples and analyzed by qRT-PCR. Total
ospC transcript from tissues infected with B. burgdorferi expressing PospC-luc was calculated for
skin, heart, bladder and tibiotarsal joint harvested day 10 and 21 post-infection (S2 FIg). Radi-
ance measured through ex vivo imaging was correlated with the total ospC transcript from each
PospC-luc infected tissue (Fig 6). All tissues displayed strong correlation between biolumines-
cence and quantitative molecular analysis. Specifically, the skin, heart, bladder, and joint
resulted in correlation values of 0.9438, 0.9609, 0.8543, and 0.8117, respectively. The correla-
tion of the bioluminescent PospC-luc signal and ospC transcripts indicates that the borrelial in
vivo PospC-luc reporter accurately represents the tissue-specific expression of native ospC in the
mammalian model and shows that the placement of the reporter construct within the shuttle
vector did not disproportionally skew the bioluminescent emission spectra detected.
In vivo expression of ospC during localized mammalian infection
The role of OspC in colonization of the murine dermis has primarily been characterizedwith
B. burgdorferi strains using ospCmutants to evaluate the presence of the pathogen and the
associated localized immune response [44,89]. To further understand the role of ospC at an
early stage of disease, PospC-luc or PflaB-luc were monitored for bioluminescent emission during
the first 96 hours (Fig 7). The post-infection luminescence is equally emitted from PospC-luc
and PflaB-luc infectedmice out to 24 hours (Fig 7). Between 24 and 48 there is a dramatic
increase in PflaB-luc luminescence that continues through 96 hours post-inoculation in a man-
ner that is statistically significant by one-way ANOVA analysis (Fig 7; p<0.0001). Quantitation
of PflaB-luc shows a 2.33-fold increase between 24 hour to 48 hours post-infection, indicating
the bacterial load dramatically increased, but, based on the PospC-luc reporter, ospC expression
did not increase with the replication of B. burgdorferi (Fig 7B). Localized infection levels
increase 9.87-fold and 32.44-fold at 72 hours and 96 hours for PflaB-luc expression relative to
PospC-luc, respectively, when compared to 24 hour luminescence levels. Differences in biolumi-
nescence emissions between PflaB-luc and PospC-luc were statistically significant at 48, 72, and
96 hour with p-values of 0.0332, 0.0350, and 0.0195, respectively. Cultivation of PospC-luc and
PflaB-luc infected skin, inguinal lymph node, and tibiotarsal joint harvested at the end point
resulted in outgrowth of cells from all tissues from both groups (data not shown). Unexpect-
edly, PospC-luc light emission showed no statistically significant change during the first 96
hours indicating that the localized expansion of B. burgdorferi does not require a correspond-
ing upsurge in ospC expression.
Discussion
The ability of B. burgdorferi to infect, disseminate, and colonize various tissues in the mamma-
lian host is dependent on its ability to adapt to temporal pressures within specific
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Fig 6. Correlation of ospC radiance and quantitationmeasure of ospC transcript inmammalian
tissues.PospC-luc infected tissues from day 10 and 21 post-infection were evaluated for radiance (p/sec/
cm2/sr) relative to total ospC transcript for the whole tissue sample. Skin (A), heart (B), bladder (C), and
tibiotarsal joint (D) had r values of 0.944, 0.961, 0.854, and 0.812, respectively.
doi:10.1371/journal.pone.0162501.g006
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Fig 7. Evaluation of ospC expression as represented by PospC-luc expressingB. burgdorferiduring
early infection. Balb/cmice infected by ventral intradermal injection with 105 PospC-luc and PflaB-luc B.
burgdorferi for the quantitationof ospC relative to bacterial load during the 96 hours following needle
inoculation. (A) Mice were treatedwith D-luciferin and imaged 2, 8, 24, 48, 72, and 96 hours with the
exception of one no D-luciferin background control at each time point. Ten minute exposures were used to
obtain images and were normalized to radiance range of 6.95x103-1.83x105 p/sec/cm2/sr. (B) Quantification
of bioluminescence was determined from 1 minute exposure images. Values represent flux (photon/sec)
normalized to background and the averaged value from four mice treatedwith D-luciferin. PospC-luc is
represented by red squares and PflaB-luc is represented by blue circles. Error bars represent standard error.
An asterisk represents p < 0.05, indicating significant differences in bioluminescence between PospC-luc and
PflaB-luc containingB. burgdorferi. Therewas no significant difference in PospC-luc radiance during the first
96 hours. One-way ANOVA of PflaB-luc radiance had a of p-value < 0.0001 indicating a statistically significant
change in luminescence.
doi:10.1371/journal.pone.0162501.g007
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microenvironments [4,6]. It is well known that B. burgdorferi undergoes dynamic gene regula-
tion as it traverses through the Ixodes vector to the mammalian dermis, but the necessary
expression of important borrelial virulencedeterminants in a temporal and tissue specificman-
ner have not been fully characterized in the murine model [19]. B. burgdorferi avoids clearance
by the innate immune response during early infection, hematogenously disseminates, and colo-
nizes distal sites such as the heart, bladder, and tibiotarsal joint. Although not formally proven,
it is evident that these tissues provide a permissible environment for borrelial adaptation and it
is likely that unique proteins are needed to establish and maintain infection at these disparate
sites [1–3]. To begin to directly address this possibility, we utilized bioluminescent B. burgdor-
feri to track infection in real time, as well as tissue specific expression of genes, using ospC as a
model for in vivo regulation relative to the constitutively expressed flaB gene. Although we
assumed that ospC expression would be restricted to early time points, our results show that
the PospC-luc reporter, as well as ospC transcripts, was detectable later in the infectious process
in various tissues, suggesting a role for OspC later in the infectious process.
Lipoproteins are abundantly represented in the B. burgdorferi envelope and diversely regu-
lated in response to environmental changes in temperature, pH, oxidative stress, CO2, O2, met-
als, and other yet to be identified host cues [4,6,90]. B. burgdorferimammalian-specific
virulence determinants are induced by the Rrp2-RpoN-RpoS regulatory pathway [4,25,26,36].
In response to a mammalian bloodmeal the response regulator, Rrp2, is phosphorylated and
forms a complex with RpoN for the transcriptional activation of rpoS [27,28,34,38]. A member
of the RpoS regulon is the surface lipoprotein OspC, which is important for the colonization of
the mammalian dermis and the development of early localized disease as evidencedby the
non-infectious phenotype of ospCmutants in both immunocompetent and immunodeficient
mice [25,35,43–47,53,88]. The presence of ospC in B. burgdorferi is important for mammalian
infection and is tightly regulated as ectopic and dysregulated overexpression of ospC can result
in the clearance of B. burgdorferi from immunocompetent mice [44,47].
The elements potentially involved in regulation in the ospC promoter, -35 sequence and
inverted repeats, have been examined in several studies in the context of single copy represen-
tation or multiple copies when PospC-ospC is encoded on a shuttle vector with differing results
[35,36,48,81].Mutational analyses of the non-coding inverted repeats of ospC were examined
in trans using E. coli as a surrogate system and directly in B. burgdorferi [35,36]. The results
indicated that these sequences were not required for the regulation of ospC; however, their abil-
ity to affect mammalian infection was not addressed [35,36]. More recently, Drecktrah et al.
performed site-directedmutagenesis of the ospC inverted repeats at its native locus on cp26
and found that these sequences were required for temperature and pH regulation of ospC [81].
Xu et al. evaluated the role of the inverted repeats during mammalian infection utilizing trans
expression of ospC [48]. Here, the inverted repeats were required for repression of ospC and
avoidance of antibody clearance in the murine model [48]. While we were restricted to the use
of a PospC-luc encoded on a shuttle vector, which has the potential to skew the expression pat-
tern under cultivation conditions, Xu et al. suggest it can appropriately represent ospC regula-
tion in the murine model.
Ideally, we would design these studies with PospC-luc encoded in single copy so that copy
number of the promoter would not represent an experimental variable, but the limitations of
the technology, specifically the intensity of light emission, prevents this from being a viable
option. Single copy luc under the control of a constitutive borrelial promoter, such as PflaB, pro-
duces substantially less light emission relative to multicopy PflaB-luc. Further, the single copy
construct was slightly above background level and lacked the sensitivity to detect significant
changes in signal intensity (Hyde, unpublished results & [91]). Further development of
ospCReporterExpression in B. burgdorferi
PLOSONE | DOI:10.1371/journal.pone.0162501 September 9, 2016 18 / 27
additional and brighter bioluminescent genes compatible with B. burgdorferi is needed to
achieve this goal.
To ensure that regulation of PospC-luc was faithful to the native ospC configuration, these
operator sequences were included in the PospC-luc reporter construct used in this study (Tables
1 & 2) [36,48,81]. The B. burgdorferi PospC-luc strain was able to regulate bioluminescence and
Luc in response to pH corresponding to that of native OspC observed in this and previous
studies (Fig 1) [13,16]. The encoding of the PospC-luc reporter cassette on a shuttle vector did
not alter the expression or production patterns under the tested conditions thereby providing
confidence the PospC-luc strain would faithfully represent in vivo expression of ospC in the
murine model. Furthermore, the changes in ospC gene expression in PospC-luc infectedmice
observedboth in vivo and ex vivo, rather than constitutive expression if regulation was not
occurring, strongly supports our contention that the shuttle vector PospC-luc reporter appropri-
ately reflects the native expression of ospC. PospC-luc bioluminescencewas further validated by
qRT-PCR of the ospC transcript (Fig 6 & S2 Fig). Here, the strong correlation seen between the
PospC-luc shuttle vector expression profile and native ospC transcript levels suggest that similar
regulatory patterns exist between these constructs (Fig 6 & S2 Fig).
The function of OspC during mammalian infection has been an elusive area of research
with data suggesting potential ligand binding capabilities and/or immune evasion. Specifically,
OspC is a homodimer in the outer membrane that is purported to bind plasminogen, as well as
the tick salivary protein, Salp15 [46,52,55,56,60,62].While OspC may bind to host factors, its
requirement during the initiation of mammalian infection suggests it plays a role in combating
the innate immune response [43–45,47,48,61]. A recent study attributed an anti-phagocytic
activity to OspC, whereby the clearance of B. burgdorferi lacking ospC by mononuclear phago-
cytes was substantially more than that observed for wild type B. burgdorferi [61].
The characterization of in vivo ospC expression at different times and in distinct niches may
provide insight into the utilization of this lipoprotein by B. burgdorferi. As a part of this study
we evaluated in vivo expression of ospC during the first 96 hours of infection and found that an
increase in borrelial load was not accompanied by a proportional rise in ospC expression, sug-
gesting limited ospC expression in the population is sufficient for colonization of mammalian
dermal tissue (Fig 7). Following the first 96 hours of infection, PospC-luc bioluminescence peaks
in the skin in vivo and ex vivo 7 days post-infection indicating colonization has occurred (Figs
2, 3 and 5A & S1A Fig). It was expected that PospC-luc would generate the observed levels of
light emission comparable or greater than PflaB-luc during the initial steps of colonization con-
sidering the essential nature of ospC during early infection, but together these results indicate
that low level ospC expression is sufficient in the skin to establish infection and that increased
levels of expression are not observeduntil one week post-inoculation.A possible drawback to
the study herein is the route of infection by needle inoculation rather than by tick transmission.
However, this methodology ensures the inoculation of a known number of B. burgdorferi. The
lack of tick transmission excludes the inhibitory activity that the salivary tick proteins afford as
well as their potential effect on borrelial gene expression. The strong correlation between lumi-
nescence and quantitated copies of ospC transcripts in the skin, and other analyzed tissues,
indicates that the PospC-luc reporter faithfully mirrors native expression (Fig 6). It is important
to note that transcription does not always translate into protein production levels and, at this
time, we are unable to quantify OspC production in tissues.
Carditis is a potential complication of Lyme diseasemaking the heart a tissue of interest in
the examination of borrelial infection and pathogenesis [1]. Experiments utilizing phage-
displayed OspC peptides were localized to heart and joint tissues, suggesting a potential role
for OspC in dissemination and colonization within these tissues [49]. Previous studies that
evaluated the expression of B. burgdorferi antigens within the heart of immunocompetent and
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immunodeficientC3Hmice showed increased bacterial burden and ospC expression, particu-
larly in the absence of the humoral immune response [47,48]. Ouyang et al. detected ospC tran-
script in the heart out to 21 days with a peak at 7 days post infection; however, no time point
prior to one week were assessed [37]. In addition, Hodzic et al. observedospC transcripts in the
base of the murine heart out to 8 weeks with an increase in expression observed at day 7 post-
infection as well [50]. However, in these studies the quantification of ospC transcripts was not
normalized to B. burgdorferi load within a given tissue; as such, it is not possible to determine if
changes in ospC expression could be attributed solely to changes in bacterial burden. One
novel finding herein indicates that ospC is expressedmost in the heart during the first 10 days
of infection, when borrelial burden is its lowest in this tissue, thereby supporting the prior
notion that OspC promotes colonization of the heart (Fig 5C) [49,50].
We also evaluated the expression of ospC within the inguinal lymph node. Despite their
important role in host defense, B. burgdorferi readily colonizes the inguinal lymph node and
remains viable throughout the course of experimental infection, as seen with the consistent
detection of bioluminescence from the PflaB-luc construct (Fig 5B & S1B Fig). Even though bor-
relial cells are present, PospC-luc B. burgdorferi emitted low level bioluminescence in inguinal
lymph node throughout the 21 days of infection, suggesting that the expression of ospC, and
presumably the production of OspC, is deleterious to B. burgdorferi in this locale (Fig 5B & S1B
Fig). Recent work showed that a B. burgdorferi ospCmutant strain was able to colonize murine
skin whenmonocytes were depleted, suggesting that OspC aids in the avoidance of phagocytic
clearance during early infection [61]. Furthermore, ospC overexpression resulted in decreased
uptake by murine macrophages. Considering the abundance of phagocytic cells that cycle
through the lymph node, the lack of ospC expression could be interpreted as contrary to the
ability of OspC to inhibit phagocytosis in macrophages [61]. However, the aforementioned
study focused on the survival of B. burgdorferi solely in the skin. Macrophages and B. burgdor-
feri are detected in several tissues in the murine model and are thus not limited to the skin.
Therefore, it would seem that OspCmight be needed elsewhere to combat the ongoing assault
by macrophages. Additional studies are necessary to clarify the role of OspC in this context.
To our surprise, ospC was expressed during later stages of the infection, particularly within
the bladder and joint (Fig 5 & S1 Fig). The murine bladder and tibiotarsal joint share the most
similar ospC expression pattern; that is, following an initial peak at day 4, a decrease is observed
at day 7 and 14, with a subsequent increase again at day 21, albeit at a low level relative to the
overall bacterial burden of these tissues (Fig 5). These findings are distinct from Ouyang et al.
observedpeak ospC expression in the bladder at day 7 and very little transcript out to day 21;
however, this study did not take changes in borrelial burden into account [37]. Hodzic et al.
was also able to detect ospC in joints during late stage infection (out to 8 weeks), although the
number of culture positive mice and the copy number of ospC transcript reduced over time
[50]. A possible reason for the sustained expression of ospC observedhere could be due to
joints being an immunoprotective niche that reduces the exposure of the pathogen to immune
pressure [92]. Both the bladder and the joint are rich in extracellularmatrices that are favored
by B. burgdorferi and present potential binding ligands for several lipoproteins, including
DbpA and BBK32 [75,79,84,93–95]. The increase in ospC expression after the colonization of
distal tissues may indicate a need for OspC to maintain infection and evade the mammalian
immune response. Two studies by Tilly et al. used a B. burgdorferi ospCmutant that encoded
an unstable copy of ospC, complemented on a shuttle vector, to evaluate the requirement for
ospC during later stages of disease [44,88]. Interestingly, their results posited that OspC is not
needed later in the infectious process, following colonization and dissemination [45]. The same
group demonstrated that passive transfer via the tissue transplant of a host adapted B. burgdor-
feri, due to the loss of the unstable shuttle vector encoding the only copy of ospC, resulted in
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positive serology in the first study and 40–67% infectivity in the second [44,88]. These studies
showed the importance of ospC for early colonization of murine dermis, but the conflicting
outcomes from the passive transfer of a borrelial ospCmutant are curious given the purported
role for OspC in dissemination or secondary colonization. Since B. burgdorferi is a metaboli-
cally limited organism that must successfully scavenge resources from the host environment to
meet basic housekeeping necessities [96], we speculate that it would not be in the best interest
of B. burgdorferi to randomly express ospC uniquely in tissues if it was not of benefit for borre-
lial infectivity and resulting pathology.
Natural B. burgdorferi infection occurs with a diversity of strains and bottlenecks occur at
several steps of the lifecycle, reducing the heterogeneity of the population [97,98]. A clonal bor-
relial infection also contains a heterogenic population with cells presenting different lipopro-
tein compositions during transmission from the tick midgut through the salivary glands to the
mammalian dermis [99]. This heterogeneous profile likely continues throughout the spread of
the pathogen and is seen by the bioluminescence data presented here in representing ospC
expression relative to the total borrelial population. It is likely that further studies will find sim-
ilar heterogeneity of other borrelial genes. Furthermore, it has been previously speculated that
the bottleneck during early mammalian infection eliminates B. burgdorferi lacking ospC
[44,45,61]. If this was the case, we would expect to observe a greater reduction of B. burgdorferi
in the first few days considering that the low level expression of ospC does not increase with
borrelial burden (Fig 6). Our work further suggests dynamic gene regulation is occurringdur-
ing murine infectionwithin a clonal B. burgdorferi population, here in the form of ospC expres-
sion, given that ospC appears to be expressed only in a fraction of the borrelial population.
Conclusion
The data presented herein indicates that bacterial burden and gene expression of ospC can be
evaluated in a temporal and spatial manner utilizing bioluminescent B. burgdorferi in the
murine experimentalmodel of infection. The ex vivo analysis allowed for a relative quantitative
assessment of differential borrelial burden in murine tissues that fluctuate over time as the
infection progressed. The requirement for ospC during early localized infectionwas not
observedwithin the first few days following needle inoculation. The unique expression of ospC
in the heart and joint, for example, using the in vivo bioluminescence reporter system relative
to traditional qRT-PCR molecular techniques suggest different requirements for OspC to
establish and maintain infection. Further studies are needed to determine the role of ospC and
other borrelial genes in persistence. Overall, this work supports a potential additional function
for OspC beyond its role in initial colonization.
Supporting Information
S1 Fig. Radiance of PflaB-luc and PospC-luc in infectedmurine tissues. Bioluminescence of
Balb/c tissues infectedwith 105 PflaB-luc or PospC-luc B. burgdorferi were evaluated for bacterial
load and ospC expression, respectively. Harvested tissues were exposed for a length of time that
allowed 600–60,000 counts to be obtained for quantification. Four tissues were normalized to
background control tissues lacking D-luciferin treatment and averaged for radiance (p/sec/
cm2/sr). Error bars represent standard error. The following tissues were evaluated for bacterial
load (PflaB-luc) and ospC expression (PospC-luc). PflaB-luc radiance was analyzed by one-way
ANOVA to determine statistical significance and displayed in [] for each tissue. (A) skin
[P = 0.0082)]; (B) heart [P = 0.0008)]; (C) inguinal lymph node [P = 0.0381)]; (D) bladder
[P = 0.0056)]; and (E) tibiotarsal joint [P = 0.0009)].
(TIF)
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S2 Fig. Quantitation of native ospC transcript by qRT-PCR. Quantitative RT-PCR shows the
total native ospC transcript of individual B. burgdorferi infectedmurine tissues. Four mouse
skin, heart, bladder and tibiotarsal joints from day 10 (dark circles) and 21 (open squares)
post-infectionwere evaluated for the total number of ospC transcripts for each tissue sample
based on a standard curve. qRT-PCR for each sample and mouse was performed in triplicate
and averaged. The error bars indicate standard error.
(TIF)
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